Tag Archives: Scott Henry

Roth Capital Thinks Lemaitre Vascular’s Stock is Going to Recover

In a report released today, Scott Henry from Roth Capital upgraded Lemaitre Vascular (NASDAQ: LMAT) to Buy, with a price target of $34. The company’s shares closed on Friday at $28.53, close to its 52-week low of $26.99. According to

Roth Capital Reiterates Their Buy Rating on BioDelivery (BDSI)

In a report issued on August 13, Scott Henry from Roth Capital reiterated a Buy rating on BioDelivery (NASDAQ: BDSI), with a price target of $4.50. The company’s shares opened today at $2.65. According to TipRanks.com, Henry is a 4-star

Roth Capital Remains a Hold on Titan Pharmaceuticals

Roth Capital analyst Scott Henry reiterated a Hold rating on Titan Pharmaceuticals (NASDAQ: TTNP) on May 18 and set a price target of $1.50. The company’s shares closed on Friday at $0.78, close to its 52-week low of $0.60. According

Roth Capital Keeps a Buy Rating on Restoration Robotics Inc

In a report released yesterday, Scott Henry from Roth Capital reiterated a Buy rating on Restoration Robotics Inc (NASDAQ: HAIR), with a price target of $11. The company’s shares closed yesterday at $7.38. According to TipRanks.com, Henry is a 2-star

Avadel Pharmaceuticals plc Gets a Buy Rating from Roth Capital

In a report released today, Scott Henry from Roth Capital reiterated a Buy rating on Avadel Pharmaceuticals plc (NASDAQ: AVDL), with a price target of $13.50. The company’s shares opened today at $9.59. According to TipRanks.com, Henry is a 1-star

Roth Capital Remains a Buy on Restoration Robotics Inc

In a report released yesterday, Scott Henry from Roth Capital reiterated a Buy rating on Restoration Robotics Inc (NASDAQ: HAIR), with a price target of $7.50. The company’s shares closed yesterday at $5.40, close to its 52-week low of $5.29.